Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
02/03/2015 | US8946420 Neuromodulatory compounds |
02/03/2015 | US8946415 Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use |
02/03/2015 | US8946413 3-aminocyclopentanecarboxamides as chemokine receptor agonists |
02/03/2015 | US8946412 Diazabicyclononyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators |
02/03/2015 | US8946406 Derivatisation of erythropoietin (EPO) |
02/03/2015 | US8946386 Proteins expressed in NK cells |
02/03/2015 | US8946304 Methods of treating malnutrition |
02/03/2015 | US8946303 Fatigue reducing agent |
02/03/2015 | US8946302 Selective sigma-1 receptor ligands |
02/03/2015 | US8946301 Targeting of T-lymphocytes to treat amyotrophic lateral sclerosis |
02/03/2015 | US8946300 Use of rasagilline for the treatment of restless legs syndrome |
02/03/2015 | US8946299 Use of calixarenes associated with an antibiotic in the treatment of bacterial infections |
02/03/2015 | US8946297 Solid composition for pest control |
02/03/2015 | US8946296 Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use |
02/03/2015 | US8946295 Histone hyperacetylating agents for promoting wound healing and preventing scar formation |
02/03/2015 | US8946294 Crystalline diacylhydrazine and the use thereof |
02/03/2015 | US8946293 Methods of intravenous administration of glyburide and other drugs |
02/03/2015 | US8946292 Formulations of low dose diclofenac and beta-cyclodextrin |
02/03/2015 | US8946291 Compositions and methods for treating pigmentary conditions and melanoma |
02/03/2015 | US8946290 Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
02/03/2015 | US8946289 Manassatin compounds and methods of making and using the same |
02/03/2015 | US8946288 Uses of hydroxyl polymethoxylflavones (HPMFs) and derivatives thereof |
02/03/2015 | US8946287 Chemotherapeutic flavonoids, and syntheses thereof |
02/03/2015 | US8946286 Organic amine salts of aminobenzoic acid derivatives and method for producing same |
02/03/2015 | US8946285 Oligomer-opioid agonist conjugates |
02/03/2015 | US8946284 Methods and compositions involving (S)-bucindolol |
02/03/2015 | US8946283 Composition for preventing or treating obesity, dyslipidemia, fatty liver or diabetes containing indole-3-carbinol derivative as active ingredient |
02/03/2015 | US8946282 Indolin-2-one derivatives as protein kinase inhibitors |
02/03/2015 | US8946281 Ketorolac tromethamine compositions for treating or preventing ocular pain |
02/03/2015 | US8946279 Fused ring compound for use as mineralocorticoid receptor antagonist |
02/03/2015 | US8946278 Inhibitors of AkT activity |
02/03/2015 | US8946277 Clonidine formulations in a biodegradable polymer carrier |
02/03/2015 | US8946276 High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis |
02/03/2015 | US8946275 Treatment of cancer using hypoxia activated prodrugs |
02/03/2015 | US8946274 Methods of improving skin quality |
02/03/2015 | US8946273 S-Triazolyl alpha-mercapto acetanilides as inhibitors of HIV reverse transcriptase |
02/03/2015 | US8946272 Plymorphic forms of deferasirox (ICL670A) |
02/03/2015 | US8946271 Water soluble furoxan derivatives having antitumor activity |
02/03/2015 | US8946269 Crystalline forms of a factor Xa inhibitor |
02/03/2015 | US8946268 Modulators of HEC1 activity and methods therefor |
02/03/2015 | US8946267 Therapeutic agent or prophylactic agent for neuropathic pain |
02/03/2015 | US8946266 Substituted triazole and imidazole derivatives as gamma secretase modulators |
02/03/2015 | US8946265 Process for the preparation of lenalidomide |
02/03/2015 | US8946264 Pyridine derivative |
02/03/2015 | US8946263 Compositions and methods for modulating circadian synchronization |
02/03/2015 | US8946262 Methods of preventing and treating gastrointestinal dysfunction |
02/03/2015 | US8946261 Substituted 1, 2, 3, 4-tetrahydroquinolin-7-yl carbamates as acetylcholinesterase inhibitors for treatment of Alzheimer's disease |
02/03/2015 | US8946260 17α-hydroxylase/C17,20-lyase inhibitors |
02/03/2015 | US8946259 Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors |
02/03/2015 | US8946258 Methods of non-gastrointestinal endoscopic procedures using L-hyoscyamine oral formulations |
02/03/2015 | US8946257 N-containing heteroaryl derivatives as JAK3 kinase inhibitors |
02/03/2015 | US8946256 Compositions and methods for treatment of vitiligo |
02/03/2015 | US8946254 Bivalent ligands for the treatment of neurological disorders |
02/03/2015 | US8946253 Systems and methods for treating an opioid-induced adverse pharmacodynamic response |
02/03/2015 | US8946252 Methods of treating traveler's diarrhea and hepatic encephalopathy |
02/03/2015 | US8946251 Method of treating thermoregulatory dysfunction with paroxetine |
02/03/2015 | US8946250 3,4-diarylpyrazoles as protein kinase inhibitors |
02/03/2015 | US8946249 Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use |
02/03/2015 | US8946248 HIV inhibiting 5-substituted pyrimidines |
02/03/2015 | US8946247 Quinazoline carboxamide azetidines |
02/03/2015 | US8946246 Synthetic rigidin analogues as anticancer agents, salts, solvates and prodrugs thereof, and method of producing same |
02/03/2015 | US8946245 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
02/03/2015 | US8946244 2′-fluoro-6′methylene carbocyclic nucleosides and methods of treating viral infections |
02/03/2015 | US8946243 Compounds and methods for the treatment of viral infection |
02/03/2015 | US8946242 Spiro[2.4]heptanes for treatment of flaviviridae infections |
02/03/2015 | US8946241 Tyrosine kinase inhibitors |
02/03/2015 | US8946240 4-amino-3-(imidazolyl)-pyrazolo[3,4-D]pyrimidines |
02/03/2015 | US8946239 Substituted pyrrolo, -furano, and cyclopentylpyrimidines having antimitotic and/or antitumor activity and methods of use thereof |
02/03/2015 | US8946238 Pyrazolo[1,5-A]pyrimidines as antiviral agents |
02/03/2015 | US8946237 Pyrazolo[1,5-A]pyrimidines as mark inhibitors |
02/03/2015 | US8946235 2-(2,4,5-substituted-anilino) pyrimidine compounds |
02/03/2015 | US8946233 Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents |
02/03/2015 | US8946232 Human protein tyrosine phosphatase inhibitors and methods of use |
02/03/2015 | US8946231 P2X3, receptor antagonists for treatment of pain |
02/03/2015 | US8946230 Aryl- and heteroaryl- nitrogen-heterocyclic compounds as PDE10 inhibitors |
02/03/2015 | US8946229 Formulations |
02/03/2015 | US8946228 Piperidine/piperazine derivatives |
02/03/2015 | US8946227 Piperazine derivatives and methods of use |
02/03/2015 | US8946226 Use of CDK inhibitor for the treatment of glioma |
02/03/2015 | US8946225 Derivatives of 2H pyridazin-3-ones, their preparation and their use as SCD-1 inhibitors |
02/03/2015 | US8946224 Substituted [1,2,4]triazolo[4,3-A]pyrazines for medicaments and pharmaceutical compositions |
02/03/2015 | US8946223 Substituted hydroxamic acids and uses thereof |
02/03/2015 | US8946222 Phenoxymethyl heterocyclic compounds |
02/03/2015 | US8946221 Phthalazine derivatives as PARP inhibitors |
02/03/2015 | US8946220 Compositions and uses thereof to ameliorate pain |
02/03/2015 | US8946219 Combination therapy with a compound acting as a platelet ADP receptor inhibitor |
02/03/2015 | US8946218 CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments |
02/03/2015 | US8946217 Pharmaceutical compounds |
02/03/2015 | US8946216 Indazole derivatives useful as ERK inhibitors |
02/03/2015 | US8946215 Hydroxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use |
02/03/2015 | US8946214 Process for the preparation of morphine analogs via metal catalyzed N-demethylation/functionalization and intramolecular group transfer |
02/03/2015 | US8946213 Alkylated piperazine compounds |
02/03/2015 | US8946212 Annelated N-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
02/03/2015 | US8946211 Fused aminodihydrothiazine derivatives |
02/03/2015 | US8946210 Fused aminodihydrothiazine derivatives |
02/03/2015 | US8946209 Compositions and methods for treating and preventing urolithiasis and conditions associated therewith |
02/03/2015 | US8946208 Non-aqueous pharmaceutical composition |
02/03/2015 | US8946207 Processes for preparing 3-benzazepines |
02/03/2015 | US8946206 Methods for improving cognitive function |
02/03/2015 | US8946205 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |